Triatomic Management LP Singular Genomics Systems, Inc. Transaction History

Triatomic Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $21,468 - $35,230	27,524 Added 16.46%	194,731 $161,000
Q1 2023 May 03, 2023	BUY	$1.1 - $2.95 $12,975 - $34,798	11,796 Added 7.59%	167,207 $202,000
Q4 2022 Feb 13, 2023	SELL	$1.82 - $2.71 $140,507 - $209,217	-77,202 Reduced 33.19%	155,411 $312,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $57,012 - $107,867	-22,805 Reduced 8.93%	232,613 $582,000
Q2 2022 Aug 12, 2022	BUY	$2.86 - $6.44 $96,410 - $217,092	33,710 Added 15.2%	255,418 $976,000
Q1 2022 May 12, 2022	SELL	$5.94 - $12.09 $1.6 Million - $3.25 Million	-268,574 Reduced 54.78%	221,708 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $5.12 Million - $8.29 Million	490,282 New	490,282 $5.67 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.56B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Triatomic Management LP, based on Form 13F filings with the SEC.

Stay updated on Triatomic Management LP with notifications on news.